Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation - Concepedia

Concepedia

Publication | Closed Access

Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation

43

Citations

43

References

2021

Year

Andrés F. Cardona, Daniel Jaramillo-Velásquez, Alejandro Ruíz-Patiño, Carolina Polo, Enrique Jiménez, Fernando Hakim, Diego Gómez, Juan Fernando Ramón, Hernando Cifuentes, Juan Armando Mejía,

Journal of Neuro-Oncology

Egfrviii MutationNeuro-oncologySimultaneous Egfr AmplificationOncologyGliomaPathologyGlioblastoma PatientsHigh-grade GliomasCancer TreatmentMedicineRadiation OncologyCancer Growth

References

	Year	Citations

Page 1

Page 1